Now Available: Enterome Bioscience SA - Product Pipeline Analysis, 2014 Update

Enterome Bioscience SA (Enterome) is a pharmaceutical company. The company offers products in the field of disease management of the human gut microbiome. Its pipeline products include MET 230 stratified nutrition test, MET 220 bariatric surgery outcome prediction, IBD 110 crohn's disease activity monitoring, and IBD 120 ulcerative colitis relapse prediction. Enterome undertakes development of personalized medical tests and companion diagnostics for microbiome-related diseases by utilizing its Metagenotyping technology. This technology helps to improve management of microbiome-related diseases such as metabolic diseases, inflammatory bowel diseases (IBD), and other related disorders. Enterome is headquartered in Paris, France.

Full Report Details at
- http://www.fastmr.com/prod/880366_enterome_bioscience_sa_product_pipeline_analysis.aspx?afid=301

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

* The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
* The report analyzes all pipeline products in development for the company Enterome Bioscience SA
* The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
* The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
* The report provides detailed description of products in development, technical specification and functions
* The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
* Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
* To formulate effective Research & Development strategies
* Develop market-entry and market expansion strategies
* Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
* Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Meridian Bioscience, Inc. (VIVO) - Product Pipeline Analysis, 2014 Update
- MDxHealth SA (MDXH) - Product Pipeline Analysis, 2014 Update
- Tosoh Bioscience, Inc. - Product Pipeline Analysis, 2014 Update
- Cepheid (CPHD) - Product Pipeline Analysis, 2014 Update
- Amarantus Bioscience Holdings, Inc. (AMBS) - Product Pipeline Analysis, 2014 Update